September 2025 • PharmaTimes Magazine • 4-5

Contents

Features

Tackling migraine’s toll is a global challenge and a major headache

Rethinking DEI across pharma – culture, courage and change

Biosimilars offer clinical value amid rising healthcare pressures

Post-marketing vaccine surveillance matters, now and for the future

How AI health diagnostics could save lives – or create new risks

Analysis

Barriers to AI adoption in pharma will impact customer experience

The case for advanced tech use to transform pharmacovigilance

Greater clinical relevance as cardiovascular outcomes trials revisited

In a world of scrolling health brands must design for reassurance

New rules of pharma marketing – navigating the maze of medicine

SmartPeople

13.
Promised land
Blended solutions gain momentum and reveal untapped potential

15.
Centre stage
Survey reveals desire for more education about breast cancer

26.
Clinical finishers
Awards show great depth of talent across sciences and nursing

36.
Move makers
Who on earth is going where and why they are going there...

38.
In the loop
Modular agents are methodically reshaping life sciences workflows